Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Circulation
|
October 25, 2017
Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells"
Jeremy Bellien, Saïd Kamel
Journal of Cardiovascular Pharmacology
|
September 27, 2012
Epoxyeicosatrienoic acid pathway in human health and diseases
Jeremy Bellien, Robinson Joannides
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 15, 2005
Flow-mediated dilatation revisited
Robinson Joannides, Jeremy Bellien
Cardiovascular & Hematological Disorders Drug Targets
|
August 5, 2014
Editorial: renal endothelial dysfunction: evolving concepts and perspectives
Dominique Guerrot, Jeremy Bellien
Fundamental & Clinical Pharmacology
|
May 5, 2006
Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries
Robinson Joannides, Jeremy Bellien, Christian Thuillez
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2008
Role of endothelium-derived hyperpolarizing factor in the regulation of radial artery basal diameter and endothelium-dependent dilatation in vivo
Jeremy Bellien, Christian Thuillez, Robinson Joannides
Fundamental & Clinical Pharmacology
|
August 19, 2008
Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans
Jeremy Bellien, Christian Thuillez, Robinson Joannides
Cardiovascular & Hematological Agents in Medicinal Chemistry
|
May 29, 2012
Diabetic CVD--soluble epoxide hydrolase as a target
Aurelien Lorthioir, Dominique Guerrot, Robinson Joannides, et al.
Atherosclerosis
|
May 4, 2019
Endothelium-dependent adaptation of arterial wall viscosity during blood flow increase is impaired in essential hypertension
Frederic Roca, Jeremy Bellien, Michele Iacob, et al.
Pharmacology & Therapeutics
|
April 26, 2011
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
Jeremy Bellien, Robinson Joannides, Vincent Richard, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Circulation
|
October 25, 2017
Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells"
Jeremy Bellien, Saïd Kamel
Journal of Cardiovascular Pharmacology
|
September 27, 2012
Epoxyeicosatrienoic acid pathway in human health and diseases
Jeremy Bellien, Robinson Joannides
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
September 15, 2005
Flow-mediated dilatation revisited
Robinson Joannides, Jeremy Bellien
Cardiovascular & Hematological Disorders Drug Targets
|
August 5, 2014
Editorial: renal endothelial dysfunction: evolving concepts and perspectives
Dominique Guerrot, Jeremy Bellien
Fundamental & Clinical Pharmacology
|
May 5, 2006
Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries
Robinson Joannides, Jeremy Bellien, Christian Thuillez
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2008
Role of endothelium-derived hyperpolarizing factor in the regulation of radial artery basal diameter and endothelium-dependent dilatation in vivo
Jeremy Bellien, Christian Thuillez, Robinson Joannides
Fundamental & Clinical Pharmacology
|
August 19, 2008
Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans
Jeremy Bellien, Christian Thuillez, Robinson Joannides
Cardiovascular & Hematological Agents in Medicinal Chemistry
|
May 29, 2012
Diabetic CVD--soluble epoxide hydrolase as a target
Aurelien Lorthioir, Dominique Guerrot, Robinson Joannides, et al.
Atherosclerosis
|
May 4, 2019
Endothelium-dependent adaptation of arterial wall viscosity during blood flow increase is impaired in essential hypertension
Frederic Roca, Jeremy Bellien, Michele Iacob, et al.
Pharmacology & Therapeutics
|
April 26, 2011
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
Jeremy Bellien, Robinson Joannides, Vincent Richard, et al.
Page
of 5